HC Wainwright & Co. : The Lyra Therapeutics (LYRA.US) rating was downgraded from buy to neutral, and the target price was $2.00.
HC Wainwright & Co.：下调Lyra Therapeutics(LYRA.US)评级，由买入调整至中性评级, 目标价2.00美元。
HC Wainwright & Co. : The Lyra Therapeutics (LYRA.US) rating was downgraded from buy to neutral, and the target price was $2.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated